An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial

by Nixon, Donald R, Simonyi, Susan, Bhogal, Meetu, Sigouin, Christopher S, Crichton, Andrew C, Discepola, Marino, Hutnik, Cindy ML, Yan, David B
Published 2012

An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan® RC Early Analysis Review (CLEAR) trial

by Crichton, Andrew C, Nixon, Donald R, Simonyi, Susan, Bhogal, Meetu, Sigouin, Christopher S, Discepola, Marino J, Hutnik, Cindy ML, Baptiste, Darryl C, Yan, David B
Published 2014